As of May 24, 2025, Trilogy International Partners Inc has a Discounted Cash Flow (DCF) derived fair value of $312.32 per share. With the current market price at $0.23, this represents a potential upside of 135689.5%.
| Key Metrics | Value |
|---|---|
| DCF Fair Value (5-year) | $278.90 |
| DCF Fair Value (10-year) | $312.32 |
| Potential Upside (5-year) | 121160.2% |
| Potential Upside (10-year) | 135689.5% |
| Discount Rate (WACC) | 6.4% - 9.3% |
Revenue is projected to grow from $239 million in 12-2022 to $903 million by 12-2032, representing a compound annual growth rate of approximately 14.2%.
| Fiscal Year | Revenue (USD millions) | Growth |
|---|---|---|
| 12-2022 | 239 | 64% |
| 12-2023 | 661 | 177% |
| 12-2024 | 690 | 4% |
| 12-2025 | 712 | 3% |
| 12-2026 | 732 | 3% |
| 12-2027 | 755 | 3% |
| 12-2028 | 797 | 6% |
| 12-2029 | 813 | 2% |
| 12-2030 | 844 | 4% |
| 12-2031 | 861 | 2% |
| 12-2032 | 903 | 5% |
Net profit margin is expected to improve from 183% in 12-2022 to 177% by 12-2032, driven by operational efficiency and economies of scale.
| Fiscal Year | Net Profit (USD millions) | Profit Margin |
|---|---|---|
| 12-2022 | 437 | 183% |
| 12-2023 | 1171 | 177% |
| 12-2024 | 1223 | 177% |
| 12-2025 | 1263 | 177% |
| 12-2026 | 1298 | 177% |
| 12-2027 | 1339 | 177% |
| 12-2028 | 1412 | 177% |
| 12-2029 | 1441 | 177% |
| 12-2030 | 1496 | 177% |
| 12-2031 | 1526 | 177% |
| 12-2032 | 1601 | 177% |
. Projected CapEx is expected to maintain at approximately 18% of revenue.
Depreciation is based on an average useful life of 5 years for capital assets.
| Fiscal Year | D&A (USD millions) |
|---|---|
| 12-2023 | 65 |
| 12-2024 | 90 |
| 12-2025 | 100 |
| 12-2026 | 106 |
| 12-2027 | 127 |
| 12-2028 | 132 |
Net working capital is expected to increase gradually, with projected changes affecting free cash flow.
| Components | Average Days |
|---|---|
| Days Receivables | 22 |
| Days Inventory | 11 |
| Days Payables | 19 |
| Fiscal Year | EBITDA | Tax | CapEx | Change in NWC | FCF |
|---|---|---|---|---|---|
| 2023 | 1371 | 71 | 118 | 33 | 1148 |
| 2024 | 1454 | 74 | 123 | (6) | 1262 |
| 2025 | 1508 | 77 | 127 | (6) | 1310 |
| 2026 | 1554 | 79 | 131 | 8 | 1336 |
| 2027 | 1619 | 81 | 135 | (2) | 1404 |
| Valuation Method | Fair Price (USD) | Potential Upside |
|---|---|---|
| 5-Year DCF (Growth) | 278.90 | 121160.2% |
| 10-Year DCF (Growth) | 312.32 | 135689.5% |
| 5-Year DCF (EBITDA) | 255.96 | 111185.1% |
| 10-Year DCF (EBITDA) | 295.26 | 128271.8% |
Is Trilogy International Partners Inc (TRL.TO) a buy or a sell? Trilogy International Partners Inc is definitely a buy. Based on our DCF analysis, Trilogy International Partners Inc (TRL.TO) appears to be significantly undervalued with upside potential of 135689.5%. The company's strong projected growth in revenue and profitability, coupled with consistent capital expenditure, supports our positive outlook on its intrinsic value.
Key investment drivers include:
Investors should consider a strong buy at the current market price of $0.23.